Reflects Growing Commitment to Renewable
Energy Sources
- Energize virtual power purchase agreement will provide the
equivalent of 25GWh of renewable energy annually
beginning in 2026
- Avantor continues to implement global solar installations,
with more planned in 2025
RADNOR,
Pa., Sept. 25, 2024 /PRNewswire/ -- Avantor,
Inc. (NYSE: AVTR), a leading global provider of mission-critical
products and services to customers in the life sciences and
advanced technologies industries, has entered into a 10-year
virtual power purchase agreement through the Energize program, a
first of its kind initiative to increase access to renewable energy
for pharmaceutical supply chains.
"This partnership reflects Avantor's continued commitment to
reducing our greenhouse gas footprint while supporting the
pharmaceutical industry in its quest to build a more sustainable
supply chain infrastructure," said Michael
Stubblefield, Avantor President and CEO. "The Energize
virtual power purchase agreement is not only an important step in
our long-term decarbonization strategy, but it also lowers the cost
to power our supply chain."
As a participant in the first cohort to come out of the Energize
Program, Avantor is supporting the development of three new solar
projects in Spain, which will
deliver new renewable electricity capacity to the European market.
Expected to come online in 2026, the project will cover Avantor's
European operations with 25GWh of renewable energy annually for 10
years. This represents an estimated 17,465 metric tons of CO2
avoided, or the equivalent of 2,278 households' annual energy
consumption for one year*.
The Energize Program is just one way in which Avantor is
investing in renewable energy. The company recently completed solar
array installations at sites in Singapore, India, Sweden, and upstate New York, with two more locations in
New Jersey expected to be
completed this year. These are part of a pipeline of additional
on-site solar projects in North
America, Europe and
Asia designed to help the Company
meet its 2030 emissions reduction targets.
Read more about Avantor's solar projects in Singapore, India and New
York here.
*Source: EPA Greenhouse Gas Emissions Equivalency
Calculator
About Avantor
Avantor® is a leading life science tools
company and global provider of mission-critical products and
services to the life sciences and advanced technology industries.
We work side-by-side with customers at every step of the scientific
journey to enable breakthroughs in medicine, healthcare, and
technology. Our portfolio is used in virtually every stage of the
most important research, development and production activities at
more than 300,000 customer locations in 180 countries. For more
information, visit avantorsciences.com and find us on LinkedIn, X
(Twitter) and Facebook.
About Energize
The Energize program is a supply chain
renewables initiative designed and delivered by Schneider Electric
Sustainability Business and endorsed by the Pharmaceutical Supply
Chain Initiative (PSCI).
Current Energize sponsor companies include: Almirall, Amgen,
AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb,
Charles River Laboratories, Chiesi Group, GSK, Haleon, Johnson
& Johnson, Kenvue, Merck (known as MSD outside the United States and Canada), Merck KGaA, Darmstadt, Germany, Novartis, Novo Nordisk, Pfizer,
Roche, Sandoz, Sanofi, Schott, Takeda, Teva, and UCB.
Global Media Contact
Eric Van
Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com
Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com
View original
content:https://www.prnewswire.com/news-releases/avantor-joins-pharmaceutical-industry-sponsored-energize-virtual-power-purchase-agreement-302257759.html
SOURCE Avantor and Financial News
